Evidence map›Paper›PMID 41888028›Full record

ArticleThe veterinary quarterly2026

A dual-gene-deleted ASFV Lv17/WB/Rie1-ΔCD candidate administered orally to wild boar confers DIVA-compatible protection against virulent challenge.

Jose A Barasona, Aleksandra Kosowska, Gabriela González-García, Marta Díaz-Frutos, Giulia Franzoni, Paola Nicolussi, Nestor Porras, Mónica Sánchez-Segovia, Daniel De Antonio-Gómez, Paloma Rueda and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The veterinary quarterly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jose A BarasonaAnimal Health Department, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Aleksandra KosowskaAnimal Health Department, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Gabriela González-GarcíaGold Standard Diagnostics Madrid SA (GSD Madrid), Madrid, Spain.
Marta Díaz-FrutosAnimal Health Department, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Giulia FranzoniIstituto Zooprofilattico Sperimentale della Sardegna, Sassari, Italy.
Paola NicolussiIstituto Zooprofilattico Sperimentale della Sardegna, Sassari, Italy.
Nestor PorrasVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.
Mónica Sánchez-SegoviaAnimal Health Department, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Daniel De Antonio-GómezAnimal Health Department, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain.
Paloma RuedaGold Standard Diagnostics Madrid SA (GSD Madrid), Madrid, Spain.
Sandra Barroso-ArévaloVISAVET Health Surveillance Center, Complutense University of Madrid, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

African swine fever (ASF) continues to expand worldwide. Recent detection in wild boar in Spain highlights the urgent need for effective control tools, with oral vaccination as a key priority. Following previous evaluation of the attenuated Lv17/WB/Rie1 strain, we assess an improved derivative, Lv17/WB/Rie1-ΔCD, lacking EP402R (CD2v) and EP153R, replaced by GFP to abrogate haemadsorption and enable Differentiating-Infected-from-Vaccinated-Animals (DIVA) diagnostics. Vaccinated animals received either a single high dose (10

Indexed as

African Swine FeverAfrican Swine Fever VirusSus scrofaViral VaccinesAdministration, OralAnimalsAntibodies, ViralGene DeletionSpainSwineVaccinationVaccines, AttenuatedVirulenceAntibodies, ViralVaccines, AttenuatedViral VaccinesAfrican swine fever virusDIVA propertieslive attenuated vaccineoral vaccinationwild boar

Identifiers

PMID41888028
PMCPMC13023007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.